Literature DB >> 2498963

Reinforcing and subjective effects of caffeine in normal human volunteers.

K N Stern1, L D Chait, C E Johanson.   

Abstract

The reinforcing and subjective effects of caffeine (100 and 300 mg, PO) were determined in a group of 18 normal, healthy adults. Subjects (eight females, ten males) were light to moderate users of caffeine, and had no history of drug abuse. A discrete-trial choice procedure was used in which subjects were allowed to choose between the self-administration of color-coded capsules containing either placebo or caffeine. The number of times caffeine was chosen over placebo was used as the primary index of reinforcing efficacy. Subjective effects were measured before and several times after capsule ingestion. The low dose of caffeine was chosen on 42.6% of occasions, not significantly different from chance (50%). The high dose of caffeine was chosen on 38.9% of occasions, significantly less than expected by chance, indicating that this dose served as a punisher. Both doses of caffeine produced stimulant-like subjective effects, with aversive effects such as increased anxiety predominating after the high dose. When subjects were divided into groups of caffeine-sensitive choosers and nonchoosers, a consistent relationship emerged between caffeine choice and subjective effects; nonchoosers reported primarily aversive effects after caffeine (increased anxiety and dysphoria), whereas choosers reported stimulant and "positive" mood effects. When compared with previous findings, these results demonstrate that caffeine is less reinforcing than amphetamine and related psychomotor stimulants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498963     DOI: 10.1007/bf00442010

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Individual differences in the reinforcing and subjective effects of amphetamine and diazepam.

Authors:  H de Wit; E H Uhlenhuth; C E Johanson
Journal:  Drug Alcohol Depend       Date:  1986-02       Impact factor: 4.492

2.  Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood.

Authors:  A Goldstein; S Kaizer; R Warren
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

3.  Caffeine content of beverages as consumed.

Authors:  R M Gilbert; J A Marshman; M Schwieder; R Berg
Journal:  Can Med Assoc J       Date:  1976-02-07       Impact factor: 8.262

4.  Effects of caffeine on anxiety and depression.

Authors:  D M Veleber; D I Templer
Journal:  J Abnorm Psychol       Date:  1984-02

5.  Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.

Authors:  S E File; A J Bond; R G Lister
Journal:  J Clin Psychopharmacol       Date:  1982-04       Impact factor: 3.153

6.  Reinforcing and subjective effects of several anorectics in normal human volunteers.

Authors:  L D Chait; E H Uhlenhuth; C E Johanson
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

7.  Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines.

Authors:  A Lelo; J O Miners; R Robson; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

8.  Anxiety and depression associated with caffeinism among psychiatric inpatients.

Authors:  J F Greden; P Fontaine; M Lubetsky; K Chamberlin
Journal:  Am J Psychiatry       Date:  1978-08       Impact factor: 18.112

Review 9.  Reinforcing properties of caffeine: studies in humans and laboratory animals.

Authors:  R R Griffiths; P P Woodson
Journal:  Pharmacol Biochem Behav       Date:  1988-02       Impact factor: 3.533

10.  Interactions of diazepam and caffeine: behavioral and subjective dose effects in humans.

Authors:  J D Roache; R R Griffiths
Journal:  Pharmacol Biochem Behav       Date:  1987-04       Impact factor: 3.533

View more
  20 in total

1.  Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.

Authors:  K Silverman; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1992-01       Impact factor: 2.468

2.  Effects of single and repeated doses of theophylline on aspects of performance, electrophysiology and subjective assessments in healthy human subjects.

Authors:  P Bartel; R Delport; B Lotz; J Ubbink; P Becker
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.

Authors:  Stacey C Sigmon; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

5.  Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption.

Authors:  Peter J Rogers; Christa Hohoff; Susan V Heatherley; Emma L Mullings; Peter J Maxfield; Richard P Evershed; Jürgen Deckert; David J Nutt
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

6.  Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money.

Authors:  Stacey C Sigmon; Jennifer W Tidey; Gary J Badger; Stephen T Higgins
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

7.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers.

Authors:  J P Zacny; J L Lichtor; W Binstock; D W Coalson; T Cutter; D C Flemming; B Glosten
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Evaluating the Validity of Caffeine Use Disorder.

Authors:  Alan J Budney; Dustin C Lee; Laura M Juliano
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.